Treatment of acute hepatitis C: recommendations from an expert panel of the Italian Society of Infectious and Tropical Diseases

Giovanni B. Gaeta; Massimo Puoti; Nicola Coppola; Teresa Santantonio; Raffaele Bruno; Antonio Chirianni; Massimo Galli

doi:10.1007/s15010-017-1107-z

Treatment of acute hepatitis C: recommendations from an expert panel of the Italian Society of Infectious and Tropical Diseases

Giovanni B. Gaeta, Massimo Puoti, Nicola Coppola, Teresa Santantonio, Raffaele Bruno, Antonio Chirianni, Massimo Galli

Research output: Contribution to journal › Review article › peer-review

Abstract

Aim: This paper is aimed at providing practical recommendations for the management of acute hepatitis C (AHC). Methods: This is an expert position paper based on the literature revision. Final recommendations were graded by level of evidence and strength of the recommendations. Results: Treatment of AHC with direct-acting antivirals (DAA) is safe and effective; it overcomes the limitations of INF-based treatments. Conclusions: Early treatment with DAA should be offered when available.

Original language	English
Pages (from-to)	183-188
Number of pages	6
Journal	Infection
Volume	46
Issue number	2
DOIs	https://doi.org/10.1007/s15010-017-1107-z
Publication status	Published - Apr 1 2018

Keywords

Acute hepatitis C
Direct-acting antivirals
Peginterferon

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1007/s15010-017-1107-z

Cite this

Treatment of acute hepatitis C : recommendations from an expert panel of the Italian Society of Infectious and Tropical Diseases. / Gaeta, Giovanni B.; Puoti, Massimo; Coppola, Nicola; Santantonio, Teresa; Bruno, Raffaele; Chirianni, Antonio; Galli, Massimo.

In: Infection, Vol. 46, No. 2, 01.04.2018, p. 183-188.

Research output: Contribution to journal › Review article › peer-review

@article{4966fc183d1f4915b89e304f52700505,

title = "Treatment of acute hepatitis C: recommendations from an expert panel of the Italian Society of Infectious and Tropical Diseases",

abstract = "Aim: This paper is aimed at providing practical recommendations for the management of acute hepatitis C (AHC). Methods: This is an expert position paper based on the literature revision. Final recommendations were graded by level of evidence and strength of the recommendations. Results: Treatment of AHC with direct-acting antivirals (DAA) is safe and effective; it overcomes the limitations of INF-based treatments. Conclusions: Early treatment with DAA should be offered when available.",

keywords = "Acute hepatitis C, Direct-acting antivirals, Peginterferon",

author = "Gaeta, {Giovanni B.} and Massimo Puoti and Nicola Coppola and Teresa Santantonio and Raffaele Bruno and Antonio Chirianni and Massimo Galli",

year = "2018",

month = apr,

day = "1",

doi = "10.1007/s15010-017-1107-z",

language = "English",

volume = "46",

pages = "183--188",

journal = "Infection",

issn = "0300-8126",

publisher = "Urban und Vogel GmbH",

number = "2",

}

TY - JOUR

T1 - Treatment of acute hepatitis C

T2 - recommendations from an expert panel of the Italian Society of Infectious and Tropical Diseases

AU - Gaeta, Giovanni B.

AU - Puoti, Massimo

AU - Coppola, Nicola

AU - Santantonio, Teresa

AU - Bruno, Raffaele

AU - Chirianni, Antonio

AU - Galli, Massimo

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Aim: This paper is aimed at providing practical recommendations for the management of acute hepatitis C (AHC). Methods: This is an expert position paper based on the literature revision. Final recommendations were graded by level of evidence and strength of the recommendations. Results: Treatment of AHC with direct-acting antivirals (DAA) is safe and effective; it overcomes the limitations of INF-based treatments. Conclusions: Early treatment with DAA should be offered when available.

AB - Aim: This paper is aimed at providing practical recommendations for the management of acute hepatitis C (AHC). Methods: This is an expert position paper based on the literature revision. Final recommendations were graded by level of evidence and strength of the recommendations. Results: Treatment of AHC with direct-acting antivirals (DAA) is safe and effective; it overcomes the limitations of INF-based treatments. Conclusions: Early treatment with DAA should be offered when available.

KW - Acute hepatitis C

KW - Direct-acting antivirals

KW - Peginterferon

UR - http://www.scopus.com/inward/record.url?scp=85038015457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038015457&partnerID=8YFLogxK

U2 - 10.1007/s15010-017-1107-z

DO - 10.1007/s15010-017-1107-z

M3 - Review article

AN - SCOPUS:85038015457

VL - 46

SP - 183

EP - 188

JO - Infection

JF - Infection

SN - 0300-8126

IS - 2

ER -

Treatment of acute hepatitis C: recommendations from an expert panel of the Italian Society of Infectious and Tropical Diseases

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this